We are live on
!
Find out more
EWM
Edge Wealth Management Portfolio holdings
AUM
$594M
1-Year Est. Return
24.92%
This Fund
S&P 500
This Quarter
Est. Return
+2.54%
1 Year Est. Return
+24.92%
3 Year Est. Return
+61.62%
5 Year Est. Return
+65.19%
10 Year Est. Return
+252.85%
AUM
$475M
AUM Growth
-$1M
(-0.21%)
Cap. Flow
-$8.95M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
58.1%
Holding
85
New
6
Increased
9
Reduced
40
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$8.83M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$551K |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$516K |
| 4 |
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
|
+$310K |
| 5 |
Home Depot
HD
|
+$215K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.94M |
| 2 |
iShares Preferred and Income Securities ETF
PFF
|
+$971K |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$861K |
| 4 |
Microsoft
MSFT
|
+$720K |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$676K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Financials | 10.29% |
| 3 | Industrials | 9.55% |
| 4 | Communication Services | 8.97% |
| 5 | Consumer Staples | 6.43% |
Similar funds
ESL
PIWA
PJSIMP
BCM
LOWM
AIP
1WCM
CAMV
Edge Wealth Management's Q2 2024 Portfolio in Review
As of Q2 2024, Edge Wealth Management held 85 positions worth $475M, down 0.21% from $476M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Edge Wealth Management's Q2 2024 filing shows 6 new, 9 increased, 40 reduced and 7 closed positions. Its largest new stake was SLB Ltd: 182,842 shares worth $8.63M. The largest sale was Pfizer, an estimated $6.94M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Edge Wealth Management's largest Q2 2024 buy was SLB Ltd: 182,842 shares worth $8.63M.
- Edge Wealth Management added most to iShares 3-7 Year Treasury Bond ETF in Q2 2024, an estimated $516K increase.
- Edge Wealth Management's biggest Q2 2024 reduction was Pfizer, cutting an estimated $6.94M.
- Edge Wealth Management fully exited Avadel Pharmaceuticals in Q2 2024, selling an estimated $676K.
- Edge Wealth Management's ten largest holdings make up 58% of its $475M portfolio in Q2 2024.
- Edge Wealth Management opened 6 new positions and closed 7 in Q2 2024.
- Edge Wealth Management's portfolio value fell 0.21% quarter-over-quarter to $475M.
Based on Edge Wealth Management's 13F filing for Q2 2024, filed 12 Jul 2024.